Suvorexant to Reduce Symptoms of Nicotine Use

Inclusion Criteria: * non-treatment seeking cigarette smokers that report smoking atleast 10 cigarettes per day Exclusion Criteria: * greater than mild substance use disorder on drugs other than nicotine * a Diagnostic and Statistical Manual of Mental Disorders(DSM)-IV axis I psychiatric disorder or neurological disease or disorder requiring ongoing treatment and/or making study participation unsafe * significant current suicidal or homicidal ideation - medical conditions contraindicating administration of suvorexant (e.g., severe pulmonary disease, severe cardiovascular disease or clinically abnormal EEG, severe liver or kidney disease, seizure disorder, or sleep disorder - particularly narcolepsy) * taking medications known to have significant drug interactions with the study medication(s) (e.g., Monoamine oxidase inhibitors(MAO) inhibitors, anticonvulsants, haloperidol, phenothiazines, anesthetics, and all sedatives) * currently or recently (last 3 months) treated for substance use \[other than nicotine\] or another psychiatric condition * conditions of probation or parole requiring reports of drug use to officers of the court * impending incarceration * pregnant or nursing for female patients * inability to read, write, or speak English \[required for lab tasks and psychometric scales\] * unwillingness to sign a written informed consent form * subjects with alcohol use disorders or report recent problem drinking (5/4 drinks for males/females in \< 2.5 hours or \> 10 al…